|
About
PTV Sciences
Pinto Technology Ventures (PTV Sciences) was founded in 2003
to invest in growth opportunities in the healthcare and life
sciences sector. We invest in companies across the United
States leveraging world-renowned resources in Texas to
create disruptive technology, compelling investment
opportunities, and life-saving change. The Firm has the
benefit of the direct experience and support of the research
institutions, academic centers, foundations, family offices,
and entrepreneurs: the "pillars of Texas" who over the last
century have been investing in and building sustainable,
successful companies in healthcare, energy, finance,
telecommunications, information technology, agriculture, and
real estate.
PTV I
closed in 2004 at $66 million with twelve investments
including two investments resulting in Initial Public
Offering and two Merger and Acquisition transactions.
PTV II
closed in 2006 at $191 million with fourteen investments.
Ten of the fourteen companies are currently reporting
revenue. Seven companies in total are based in Texas.
Commitment
Our first
commitment is to our investors. Every decision we make is
formed with the distinct goal of delivering tangible results
that provide a substantial and superior return to our
investors. Our “real products, real revenue” risk
mitigation approach has lead to a robust portfolio offering
for or investors.
Our second
commitment is to serve the extraordinary entrepreneurs that
are enabling the “next generation” of modern healthcare. We
are committed to creating significant value in every
interaction we have with the scientists, inventors,
innovators, and business leaders who lead our investment
portfolio companies.
Our third commitment is to building and strengthening
partnerships. Our collaborative model allows us to maximize
value creation across the spectrum of our investments. We
welcome the participation of experienced venture capital
firms and our strategic partners in helping to create some
of tomorrows most exciting and game-changing companies.
Focus
PTV Sciences
has focused on healthcare companies in markets with
significant unmet clinical or infrastructure needs and help
ensures their success by providing them access to critical
business development resources, including capital, guidance
and strategic partnerships. To date, PTV has invested in
over twenty-six companies.
PTV Sciences’ investment strategy focuses
on the healthcare sector, including medical devices,
diagnostics and a limited number of lower risk biotechnology
and pharmaceutical opportunities. PTV has a specific focus
on companies located in Texas, the Southwest and the U.S
with an emphasis on investments that have (1) proprietary
technologies; (2) the potential for dramatic growth; (3)
compelling business strategies; (4) near term revenue; and
(5) opportunities for substantial financial return.
We put the utmost
importance on highly dedicated and innovative management
teams AND sound medical science with a true line of sight to
end goals. It is from the basis that PTV can leverage its
vast wealth of regulatory, financial, and industry knowledge
to help bring these emergent companies through the hurdles
of expansion.
PTV Sciences has a
highly collaborative investment team of professionals,
deeply experienced as investors and operators of healthcare
companies. We take pride in our active involvement and
regularly providing direction on executive recruitments,
research and development strategies, corporate agreement
structuring, and financial modeling.
Submit a Business Plan:
Contact
Drive
As a team of
investment professionals, our focus on innovation drives our
desire to make a difference in the work that we do.
We truly believe that we
play a significant role in shaping the future of healthcare
through our focus on cost effective, clinically relevant,
and efficient delivery of modern healthcare technology. It
is because of this view that we strive to be industry
leaders and guide our portfolio companies so that the future
of medical technology will continue to save and improve
lives well beyond tomorrow. |
